Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_assertion type Assertion NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_head.
- NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_assertion description "[Studies of glioma xenografts suggest that they may be amenable to gene therapy with cytotoxic genes, such as the proapoptotic Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_provenance.
- NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_assertion evidence source_evidence_literature NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_provenance.
- NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_assertion SIO_000772 17178885 NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_provenance.
- NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_assertion wasDerivedFrom befree-20150227 NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_provenance.
- NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_assertion wasGeneratedBy ECO_0000203 NP805946.RAdcygKT0piw-Cr2tXt0iaLIFU0x2M3gWCdaiGADZQgTI130_provenance.